Purdue

In May 2018, Attorney General Josh Stein sued drug maker Purdue Pharma over deceptive marketing practices that created and fueled the opioid epidemic. In September 2019, he sued eight members of the Sackler family alleging they were the driving forces behind Purdue Pharma’s misconduct.

In July 2021, after years of negotiation, Attorney General Stein announced his support for confirmation of a bankruptcy plan for Purdue Pharma that would make billions of dollars available nationwide to fund efforts to remediate the opioid crisis.  This includes an estimated $100 million coming to North Carolina communities to support treatment, recovery, harm reduction, and other life-saving programs and services.  Read the announcement.

In December 2021, a federal court ruled the plan proposed by Purdue Pharma did not comply with bankruptcy law.  Resolution of the Purdue Pharma bankruptcy is on hold while the ruling is being appealed.  The federal court’s decision does not affect the separate settlement with the distributors and Johnson & Johnson.

Teva

On July 26, 2022, Attorney General Josh Stein announced he has reached an agreement in principle on key financial terms with opioid maker Teva, which would provide up to $4.25 billion over 13 years to participating states and local governments. Read the press release. Negotiations are underway on the settlement’s final terms, including the amount to be received by North Carolina and the process for local governments to join the settlement.

Allergan

On July 29, 2022, Attorney General Josh Stein announced an agreement in principle with opioid manufacturer Allergan to pay up to $2.37 billion over six years to participating states and local governments.  Read the press release. Negotiations are underway on the settlement’s final terms, including the amount to be received by North Carolina and the process for local governments to join the settlement.

Endo

On August 17, 2022, Attorney General Josh Stein announced an agreement in principle with opioid maker Endo International plc and its lenders that would provide up to $450 million over 10 years to participating states and local governments and ban promotion of Endo’s opioids. Read the press release. As part of the agreement, Endo filed for bankruptcy and a bankruptcy court must approve the settlement’s final terms.